AG 555 NEW
| Price | $64 | $113 | $172 |
| Package | 10mg | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: AG 555 | CAS No.: 133550-34-2 |
| Purity: 99.94% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | AG 555 |
| Description | AG 555 (Tyrphostin B46) is an EGFR tyrosine kinase inhibitor. |
| In vitro | Cell incubation in the presence of 30 μM AG 555 results in a selective down-regulation of the most abundant viral transcripts already 4 h after drug application. AG55 inhibits the growth of HPV16-immortalized cells. AG555 is already effective at 10 μM (IC50=6.4, respectively), and the cells remain arrested after withdrawal of the compound on day 5 as monitored on days 8 and 12. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 122.5 mg/mL (380.01 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (6.2 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (31.02 mM), Suspension. |
| Keywords | Tyrphostin AG-555 | Tyrphostin AG555 | ReverseTranscriptase | Reverse Transcriptase | Papillomavirus | Inhibitor | inhibit | HER1 | ErbB-1 | Epidermal growth factor receptor | EGFR | BPV | Bovine | antiretroviral | AG-555 | AG555 | AG 555 |
| Inhibitors Related | Stavudine | Emtricitabine | Osimertinib | Lamivudine | Tenofovir Disoproxil Fumarate | Lapatinib | Erlotinib | Neratinib | Tenofovir alafenamide | Afatinib | Gefitinib | Tenofovir |
| Related Compound Libraries | Apoptosis Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Hematonosis Compound Library | Anti-Breast Cancer Compound Library | Anti-Viral Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $3770.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-21 | |
|
VIP3Y
|
Chongqing Zhihe Biopharmaceutical Co., Ltd.
|
2026-05-20 | ||
| $30.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY